Recently appointed distributors in Korea and the US have been successful in obtaining hospital approvals for LiVac clinical evaluations with clinical utility in Korea already underway.
SurgiCore, Inc. (USA) has been successful in obtaining four hospital Internal Review Board (IRB) approvals. The first clinical use of the LiVac Retractor in the US is now imminent.
MediFocus Co. Ltd. (Korea) has worked with a leading bariatric surgeon, Prof Y J Kim, to obtain IRB approval for the LiVac Retractor at Yangji Hospital, Seoul.
Prof. Y J Kim has completed a small number of LiVac cases and quoted, “the LiVac device is simple and effective to use.”